Crossmark

Newly diagnosed type 1 diabetes mellitus in a human immunodeficiency virus-infected patient with antiretroviral therapy-induced immune reconstitution inflammatory syndrome: a case report

Crossref DOI link: https://doi.org/10.1186/s12879-023-08605-1

Published Online: 2023-09-20

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Min-ChunYeh,

Chuang, Han-Chuan

Weng, Shuen-Fu

Hsu, Chung-Huei

Huang, Chen-Ling

Lin, Yu-Pei

Lin, Yan-Yu

Hsieh, Yu-Shan
License Information

Text and Data Mining valid from 2023-09-20

Version of Record valid from 2023-09-20
More Information

Article History

Received: 24 April 2023

Accepted: 12 September 2023

First Online: 20 September 2023

Declarations

:

: This study was performed in accordance with the Declaration of Helsinki and was approved by The Taipei Medical University Hospital (TMUH) Institutional Review Board for Clinical Research approved this study (No. N202302044). Clinical participant provided written informed consent to participate in the study.

: Clinical participant provided written informed consent to publication in the study.

: The authors declare no competing interests.

Document is current

Any future updates will be listed below